Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score–Matched Analysis From 130 US Hospitals - Kadri, Sameer S.; Swihart, Bruce J.; Bonne, Stephanie L.; Hohmann, Samuel F.; Hennessy, Laura V.; Louras, Peter; Evans, Heather L.; Rhee, Chanu; Suffredini, Anthony F.; Hooper, David C.; Follmann, Dean A.; Bulger, Eileen M.; et al. (Clinical infectious diseases, 2017)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics; ARTICLES AND COMMENTARIES; Comorbidity; Editor's Choice; Fasciitis, Necrotizing - complications; Fasciitis, Necrotizing - diagnosis; Fasciitis, Necrotizing - drug therapy; Fasciitis, Necrotizing - mortality; Female; Hospital Mortality; Hospitals; Humans; Immunoglobulins; Immunoglobulins, Intravenous - therapeutic use; Major; Male; Middle Aged; Mortality; Odds Ratio; Propensity Score; Retrospective Studies; Severity of Illness Index; Shock - complications; Shock - diagnosis; Shock - drug therapy; Shock - mortality; Shock, Septic - complications; Shock, Septic - drug therapy; Shock, Septic - mortality; Staphylococcus aureus; Staphylococcus infections; Streptococcus; Streptococcus pyogenes; Treatment Outcome; United States; Young Adult; United States--US; toxic shock; intravenous immunoglobulin; necrotizing fasciitis